U.S. markets open in 34 minutes
  • S&P Futures

    -42.25 (-1.10%)
  • Dow Futures

    -321.00 (-1.04%)
  • Nasdaq Futures

    -110.75 (-0.82%)
  • Russell 2000 Futures

    -44.60 (-2.08%)
  • Crude Oil

    -0.10 (-0.19%)
  • Gold

    -11.90 (-0.64%)
  • Silver

    -0.42 (-1.64%)

    -0.0055 (-0.45%)
  • 10-Yr Bond

    -0.0260 (-2.50%)
  • Vix

    +3.94 (+16.99%)

    -0.0041 (-0.30%)

    +0.3530 (+0.34%)

    -1,006.70 (-3.19%)
  • CMC Crypto 200

    -24.44 (-3.82%)
  • FTSE 100

    -93.08 (-1.40%)
  • Nikkei 225

    +89.03 (+0.31%)

Here's What To Make Of Ultralife's (NASDAQ:ULBI) Returns On Capital

Simply Wall St
·3 min read

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. However, after investigating Ultralife (NASDAQ:ULBI), we don't think it's current trends fit the mold of a multi-bagger.

What is Return On Capital Employed (ROCE)?

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. Analysts use this formula to calculate it for Ultralife:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.059 = US$7.0m ÷ (US$136m - US$17m) (Based on the trailing twelve months to September 2020).

Thus, Ultralife has an ROCE of 5.9%. Ultimately, that's a low return and it under-performs the Electrical industry average of 8.3%.

View our latest analysis for Ultralife


While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you're interested in investigating Ultralife's past further, check out this free graph of past earnings, revenue and cash flow.

The Trend Of ROCE

In terms of Ultralife's historical ROCE trend, it doesn't exactly demand attention. Over the past five years, ROCE has remained relatively flat at around 5.9% and the business has deployed 69% more capital into its operations. This poor ROCE doesn't inspire confidence right now, and with the increase in capital employed, it's evident that the business isn't deploying the funds into high return investments.

What We Can Learn From Ultralife's ROCE

Long story short, while Ultralife has been reinvesting its capital, the returns that it's generating haven't increased. And investors may be recognizing these trends since the stock has only returned a total of 21% to shareholders over the last five years. As a result, if you're hunting for a multi-bagger, we think you'd have more luck elsewhere.

If you want to continue researching Ultralife, you might be interested to know about the 2 warning signs that our analysis has discovered.

For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.